SPRAY VENTURE PARTNERS
Spray Venture Partners focuses exclusively on contributing capital and expertise to emerging healthcare technology companies. They work closely with clinical and technical founders to create companies that develop, market and deploy innovative technologies to meet major unmet healthcare needs.
SPRAY VENTURE PARTNERS
Industry:
Emerging Markets Finance Venture Capital
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft DNS
Similar Organizations
Rogue Venture Partners
Rogue Venture Partners is a local venture capital fund investing in disruptive entrepreneurs and start-ups.
Wasabi Ventures
Wasabi Ventures has planned, implemented, and maintained solutions for many early-stage startups.
Current Employees Featured
Lisa Dunlea
Lisa Dunlea Team Member @ Spray Venture Partners Team Member
Daniel Cole
Daniel Cole General Partner @ Spray Venture Partners General Partner 1996-01-01
Kevin Connors
Kevin Connors Founder & General Partner @ Spray Venture Partners Founder & General Partner 1996-01-01
Founder
Kevin Connors
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2013-10-03 | Conventus Orthopaedics | Spray Venture Partners investment in Venture Round - Conventus Orthopaedics | 11.5 M USD |
2013-01-07 | Tryton Medical | Spray Venture Partners investment in Venture Round - Tryton Medical | 24 M USD |
2012-04-01 | Direct Flow Medical | Spray Venture Partners investment in Venture Round - Direct Flow Medical | 284 K USD |
2012-03-28 | Solace Therapeutics | Spray Venture Partners investment in Venture Round - Solace Therapeutics | 7 M USD |
2011-01-04 | PneumRx | Spray Venture Partners investment in Venture Round - PneumRx | 33 M USD |
2010-09-14 | Tryton Medical | Spray Venture Partners investment in Series D - Tryton Medical | 20 M USD |
2010-05-06 | TearScience | Spray Venture Partners investment in Series C - TearScience | 44.5 M USD |
2010-02-26 | Intrinsic Therapeutics | Spray Venture Partners investment in Venture Round - Intrinsic Therapeutics | 18 M USD |
2009-10-05 | Direct Flow Medical | Spray Venture Partners investment in Series C - Direct Flow Medical | 40 M USD |
2009-07-07 | Interlace Medical | Spray Venture Partners investment in Series C - Interlace Medical | 20.5 M USD |